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128The inﬂuence of gender on functional outcomes of
lower extremity bypass
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Philip P. Goodney, MD,c Michael A. Ricci, MD,d Jack L. Cronenwett, MD,c andDaniel J. Bertges, MD,a for
the Vascular Study Group of New England, Burlington, Vt; Worcester, Mass; Lebanon, NH; and Lewiston, Me
Objective: Our aim was to evaluate the effect of gender on early and late procedural and functional outcomes of lower
extremity bypass (LEB).
Methods: We reviewed the records of 2576 patients (828 women; 32%) who underwent LEB for claudication or critical
limb ischemia (CLI) in the Vascular Study Group of New England from 2003 to 2010. Logistic regression and
proportional hazards models were used to adjust for potential confounding differences between genders. Morbidity,
mortality, graft patency, freedom from major amputation, ambulation, and living status were analyzed postoperatively
and over 1 year.
Results: Women were older (70 vs 68 years; P < .001), had more hypertension (89% vs 85%; P [ .006), less coronary
artery disease (35% vs 39%; P[ .03), smoking (73% vs 88%; P < .001), and preoperative statin use (60% vs 64%; P[ .04).
Women were more likely to have CLI (76% vs 71%; P[ .003), and ambulate with assistance at presentation (19% vs 16%;
P [ .02). Morbidity was similar except women had higher rates of reoperation for thrombosis (4% vs 2%; P < .001)
without differences in major amputation (2% vs 1%; P [ .13) or in-hospital mortality (1.7% vs 1.7%; P [ .96). Women
and men with claudication had similar 1-year graft patency rates. Women with CLI had lower rates of primary (hazard
ratio [HR], 1.24; 95% conﬁdence interval [CI], 1.03-1.48; P [ .02), assisted primary (HR, 1.42; 95% CI, 1.15-1.76;
P [ .001) and secondary patency (HR, 1.40; 95% CI, 1.10-1.77; P [ .006) during the ﬁrst year compared with men.
Freedom from amputation was similar for men and women with CLI (HR, 1.17; 95% CI, 0.84-1.63; P [ .36). There
were no differences in late survival between women and men with claudication (HR, 0.89; 95% CI, 0.60-1.31; P[ .36)
or CLI (HR, 0.94; 95% CI, 0.81-1.09; P [ .39). More female claudicants were not independently ambulatory at
discharge (30% vs 19%; P[ .002) and were discharged to a nursing home (15% vs 5%; P < .001) but these differences did
not persist at 1 year. Women with CLI were more likely to be nonambulatory at discharge (13% vs 9%; P[ .006) and at
1 year (13% vs 8%; P < .001). More women with CLI were discharged to a nursing home (44% vs 35%; P [ .01) and
resided there at 1 year (11% vs 7%; P [ .02).
Conclusions: Women have complication rates similar to men with inferior early and late functional outcomes after LEB.
The reduced patency rates in women with CLI did not translate into differences in limb salvage. These ﬁndings might help
deﬁne physician and patient expectations for women before revascularization. (J Vasc Surg 2014;60:1282-90.)Historically, traditional outcomes such as graft
patency, limb salvage, and mortality have been used to
deﬁne the success of infrainguinal lower extremity bypass
(LEB) with relatively less emphasis placed on functional
outcomes. However, functional long-term outcomes, spe-
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2independence, ultimately correlate with improved patient
quality of life.
Several studies have reported predictors of successful
ambulation after LEB.1-5 Although female gender has
been identiﬁed in some studies as an independent risk fac-
tor for inferior outcomes such as patency, infection, and
mortality after LEB, few studies have speciﬁcally evaluated
the association between gender and functional outcomes.6-
11 The primary aim of this study was to elucidate gender
differences in functional outcomes including 1-year ambu-
lation and living status among patients undergoing LEB for
claudication or critical limb ischemia (CLI). A secondary
aim was to compare rates of early and late morbidity, mor-
tality, graft patency, and freedom from amputation accord-
ing to gender.
METHODS
Patients and databases. We reviewed prospectively
collected data on 2576 patients (828 women; 32%)
who underwent infrainguinal LEB in the Vascular Study
Group of New England (VSGNE), a cooperative quality
improvement initiative developed in 2002 to study and
improve regional outcomes in vascular surgery.12
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lished and are available at https://www.vascularweb.
org/regionalgroups/vsgne/Pages/home.aspx.
Consecutive infrainguinal bypasses for CLI (n ¼ 1864)
and claudication (n ¼ 712), from January 2003 to June
2010 were included. Percutaneous vascular interventions
and patients with aneurysmal disease were excluded. Pa-
tients who underwent multiple bypasses were included
based on their initial intervention so that the number of pa-
tients and bypass grafts was equivalent.
Deﬁnitions and outcome measures. As previously
described, data on >100 clinical and demographic variables
were collected for each patient and prospectively entered
into the VSGNE registry.12 Our primary outcome mea-
sures were ambulatory status and living status at discharge
and at 1-year follow-up.
Within the VSGNE database, ambulatory status was
classiﬁed preoperatively, at discharge, and at 1-year
follow-up in four ways: (1) independent, (2) with assistance
including use of a cane or walker, (3) wheelchair, or (4)
bedridden. Because the number of patients in the wheel-
chair and bedridden categories was small we combined
them into one group called nonambulatory. Therefore,
our analysis of ambulation was based on three categories:
nonambulatory, ambulatory with assistance, and indepen-
dent. Living status was categorized as living at home or
in a nursing home and was evaluated preoperatively, at
discharge, and at 1-year follow-up. Analysis of ambulatory
and living status was based on indication for bypass of clau-
dication or CLI.
Secondary outcome measures included in-hospital
mortality and morbidity including wound or graft infection,
cardiac and pulmonary complications, renal insufﬁciency,
and reoperation for bleeding, thrombosis, infection, or
graft revision. These outcomes were deﬁned using
previously described deﬁnitions available at: http://www.
vascularqualityinitiative.org/about/procedures-collected.
Mortality, bypass patency, and freedom from major ampu-
tation (belowor above the knee)were analyzed at discharge
and at long-term follow-up. Graft surveillance was per-
formed according to individual surgeon practice and
method of determining patency was coded as Doppler
only, palpable graft pulse, palpable distal pulse, ankle-
brachial index increase >0.15, or using duplex. Data anal-
ysis for discharge and follow-up was restricted only to pa-
tients who survived and had long-term data. Across the
study group, 5.4% of women and 6.3% of men were lost
to follow-up. Follow-up for ambulation and living status
was at a mean of 347 days and median of 335 days after
LEB. Follow-up data for survival analysis was calculated at
a mean of 1441 days and a median of 1330 days using the
Social Security Death Index.
Statistical analysis. Univariate analysis was performed
to compare preoperative, operative, and postoperative char-
acteristics between genders. Risk factors found to differ
signiﬁcantly between genders were then included in a multi-
variable logistic regression model to adjust for baseline
differences between genders. Potential confounders includedage, race, smoking, coronary artery disease, hypertension,
indication (claudication, rest pain, tissue loss), preoperative
ambulation, statin use, graft origin and recipient, conduit
type, and length of follow-up. Logistic regression was used
to analyze differences in ambulation and living status at
discharge and long-term follow-up based on indication
and gender. Kaplan-Meier analysis was used to compare
long-term mortality, bypass patency, and freedom from
amputation during the ﬁrst year, using proportional hazards
regression to adjust for potentially confounding differences
between genders, which was stratiﬁed by indication. Statis-
tical signiﬁcance was designated by a P-value < .05. Data
were analyzed using SAS version 9.3 (SAS Institure, Cary,
NC). The Committee for the Protection of Human Subjects
at Dartmouth College and the Institutional Review Board of
theUniversity of VermontCollege ofMedicine has approved
research analyses basedondeidentiﬁeddata fromtheVSGNE
without requiring consent.RESULTS
Preoperative and operative characteristics accord-
ing to gender. Most revascularizations were performed for
CLI in women and men (76% vs 71%; P ¼ .003) (Table I).
At baseline, women were older with higher rates of hy-
pertension but a lower prevalence of smoking and coronary
artery disease. Women were less likely to be using a statin
perioperatively. Preoperatively, women were more likely to
be nonambulatory (6% vs 5%; P ¼ .05) or ambulating with
assistance (19% vs 16%; P ¼ .02). There were no differ-
ences in preoperative living status among men and women.
Tibial (31% vs 26%; P ¼ .04) and pedal targets (11% vs 8%;
P ¼ .006) were used more often in men compared with
women. Prosthetic infrainguinal grafts were used more
frequently in women (30%) compared with men (23%). A
small number (n ¼ 21; 1%) of bypasses were performed for
patients reported to be bedridden. Although further detail
was not available, the indication might have been to pre-
serve transfer ability in these patients.
Early postoperative outcomes. Postoperative compli-
cations were similar among genders except women had a
higher rate of reoperation for graft thrombosis (4% vs 2%;
P < .001) (Table II). There was no difference in in-
hospital superﬁcial wound infections for women vs men
(6% vs 5%;P¼ .07). At discharge, primary patencywas 94.3%
vs 95.9% (P¼ .07) and assisted primary patencywas 95.8% vs
97.6% (P ¼ .23) in women and men, respectively. When
combining primary and assisted primary patency rates
together there was a signiﬁcant difference between genders
compared with secondary patency and occluded graft (P ¼
.02). Graft occlusion was greater in women (2.5% vs 1.3%;
P ¼ .03). There were statistical differences in overall ampu-
tation rates across genders (P ¼ .03). Major ipsilateral
amputation rates in-hospital were comparable between
genders (2% vs 1%; P ¼.13), although women had fewer
minor amputations (7% vs 10%; P ¼ .03). In-hospital mor-
talitywas equal at 1.7% for both genders. Themean length of
stay was 8.5 days for women and 7.7 days for men (P¼ .06).
Table I. Preoperative and operative characteristics according to gender
Women, mean (SD) or No. (%) (n ¼ 828) Men, mean (SD) or No. (%) (n ¼1748) Pa
Age, years 70 (12) 68 (11) <.001
Nonwhite race 10 (1) 42 (2) .04
Not living at home 35 (4) 63 (4) .45
Ambulatory status
Ambulatory 615 (74) 1383 (79) .04 (across groups)
Ambulatory with assist 161 (19) 281 (16)
Nonambulatory 52 (6) 82 (5)
Wheelchair 45 (5) 68 (4)
Bedridden 7 (1) 14 (1)
Smoking current/past 607 (73) 1541 (88) <.001
COPD 223 (27) 519 (30) .15
Diabetes 438 (53) 900 (51) .50
CAD 289 (35) 689 (39) .03
CHF 147 (18) 289 (17) .43
Hypertension 736 (89) 1483 (85) .006
Dialysis 56 (7) 124 (7) .76
Previous bypass 179 (22) 434 (25) .08
Indication
Claudication 197 (24) 515 (29) .003 (across groups)
CLI 631 (76) 1233 (71)
Anti-platelet 615 (74) 1301 (74) .92
Statin 497 (60) 1121 (64) .04
b-blocker
None 168 (20) 301 (17) .02 (across groups)
Perioperative 166 (20) 424 (24)
Chronic 489 (59) 1008 (58)
Graft origin
CFA 590 (71) 1213 (70) <.001 (across groups)
External iliac 25 (3) 24 (1)
Superﬁcial femoral 141 (17) 301 (17)
Profunda 28 (3) 43 (2)
Popliteal 42 (5) 158 (9)
Tibial 2 (<1) 6 (<1)
Graft recipient
Below-knee popliteal 276 (33) 545 (31) <.001 (across groups)
Above-knee popliteal 250 (30) 444 (25)
SFA/profunda 20 (2) 23 (1)
Tibial 216 (26) 535 (31)
Pedal/crural 65 (8) 199 (11)
Conduit
Vein 552 (67) 1293 (74) <.001 (across groups)
Dacron 26 (3) 26 (1)
PTFE 225 (27) 383 (22)
Nonautologous 20 (2) 38 (2)
Composite with vein 5 (1) 8 (<1)
CAD, Coronary artery disease; CFA, common femoral artery; CHF, congestive heart failure; CLI, critical limb ischemia; COPD, chronic obstructive pul-
monary disease; PTFE, polytetraﬂuoroethylene; SD, standard deviation; SFA, superﬁcial femoral artery.
at-test for age, c2 test for categorical variables.
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and overall survival. For patients with CLI, primary
patency during the ﬁrst year was less in women compared
with men (hazard ratio [HR], 1.24; 95% conﬁdence inter-
val [CI], 1.03-1.48; P ¼ .02). Assisted primary patency
(HR, 1.42; 95% CI, 1.15-1.76; P ¼ .001) and secondary
patency (HR, 1.40; 95% CI, 1.10-1.77; P ¼ .006) were
also less in women with CLI. There were no statistically
signiﬁcant differences in patency in comparison of female
and male claudicants (primary: HR, 1.36; 95% CI, 0.95-
1.97; P ¼ .10; assisted primary: HR, 1.45; 95% CI, 0.87-
2.41; P ¼ .15; secondary: HR, 1.51; 95% CI, 0.82-2.79;
P ¼ .18, respectively; Fig 1).Freedom from major amputation during 1-year follow-
up was similar for men and women with claudication (HR,
0.85; 95% CI, 0.06-12.49; P ¼ .91) or CLI (HR, 1.17;
95% CI, 0.84-1.63; P ¼ .36; Fig 2). Rates for freedom
from amputation at 1 year for women and men were 98%
vs 99% for claudicants and 88% vs 87% for CLI, respec-
tively. There were no differences in long-term survival
(mean follow-up, 1441 days) between men and women
with claudication (HR, 0.89; 95% CI, 0.60-1.31; P ¼
.36) or CLI (HR, 0.94; 95% CI, 0.81-1.09; P ¼ .39;
Fig 3). One-year survival was 98% for women compared
with 96% for men with claudication and 82% for women
compared with 84% for men with CLI.
Table II. Postoperative characteristics according to gender
Women, No. (%) Men, No. (%) Pa
Surgical site infection 53 (6) 82 (5) .07
Graft infection 4 (<1) 5 (<1) .43
POMI 43 (5) 66 (4) .09
Respiratory .57 (across groups)
None 812 (98) 1707 (98)
Pneumonia 5 (1) 15 (1)
Ventilator dependence 9 (1) 26 (1)
Change in renal function 36 (5) 78 (5) .93
Reason for repeat surgery
Bleeding 11 (1) 29 (2) .53
Thrombosis 35 (4) 33 (2) <.001
Infection 10 (1) 12 (1) .18
Revision 24 (3) 39 (2) .30
Ipsilateral amputation
None 753 (91) 1560 (89) .03 (across groups)
Minor 57 (7) 166 (10)
Major 16 (2) 20 (1)
Discharge patency
Primary 775 (94) 1668 (96) .11 (across groups)
Primary-assisted 13 (1.5) 29 (1.7)
Secondary 13 (1.5) 18 (1.0)
Occluded 21 (2.5) 24 (1.3)
Discharge medications
Antiplatelet 676 (83) 1429 (83) .79
Statin 379 (70) 875 (75) .01
b-blocker 429 (79) 943 (81) .27
Warfarin 191 (23) 395 (23) .83
Mean LOS 6 SD, days 8.5 6 9.8 7.7 6 11.2 .06
Death (in-hospital) 14 (1.7) 30 (1.7) .96
LOS, Length of stay; POMI, postoperative myocardial infarction; SD, standard deviation.
at-test for age, c2 test for categorical variables.
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tus. We found a transient loss in independent ambula-
tion postoperatively among claudicants in men and
women (Fig 4, A). More female claudicants (30%) were
able to ambulate with assistance compared with only 19%
of men at discharge (P ¼ .003). Despite this decrease in
early postoperative ambulation, most female claudicants
regained independent ambulation by 1-year follow-up
with only 3% requiring assistance compared with 1% of
men (P ¼ .20).
Among patients with CLI, nearly half of men and
women were able to ambulate with assistance at discharge
(Fig 4, B). Women were more likely to be completely non-
ambulatory at discharge compared with men (13% vs 9%;
P ¼ .002). This ambulation gap persisted at 1-year
follow-up with more women wheelchair-bound or
bedridden compared with men (13% vs 8%; P < .001).
When compared with their preoperative ambulatory status
an additional 5% of women became nonambulatory at
1 year compared with an additional 2% of men (P ¼ .007).
In multivariate analysis, women with CLI were more
likely to ambulate with assistance (odds ratio [OR], 1.3;
95% CI, 1.0-1.6; P ¼ .02) or be nonambulatory (OR, 2.0;
95% CI, 1.3-3.0; P < .001) at discharge (Supplementary
Table, online only). This association persisted at the 1-year
follow-up with more women having a greater likelihood
of ambulating with assistance (OR, 1.4; 95% CI, 1.0-2.0;P ¼ .08) or being nonambulatory (OR, 2.4; 95% CI,
1.6-3.7; P < .001) compared with men with CLI.
Although most patients were living at home before sur-
gical intervention, a signiﬁcant proportion of patients were
discharged to a nursing facility. Women with claudication
were three times more likely to be discharged to a nursing
home postoperatively in contrast to men (15% vs 5%;
P < .001; Fig 5, A). However, at the 1-year follow-up,
only 1% of female and male claudicants were not living at
home. A signiﬁcant percentage of women with CLI were
discharged to a nursing home compared with men (44%
vs 35%; P ¼ .01; Fig 5, B). We found a persistent loss in
independent living at 1 year among women with CLI
(11% vs 7%; P ¼ .02). Furthermore, more women with
CLI who were initially discharged to home were living in
a nursing home at the 1-year follow-up (5% vs 2%; OR,
2.5; 95% CI, 1.2-5.2; P ¼ .01).
In multivariate analysis, female gender was associated
with discharge to a nursing home in claudicants (OR,
4.3; 95% CI, 2.2-8.1; P < .001; Supplementary Table,
online only). Female gender was also associated with
nursing home residence at discharge (OR, 1.3; 95% CI,
1.1-1.7; P ¼ .01) and at 1 year (OR, 1.7; 95% CI, 1.1-
2.8; P ¼ .02) in patients with CLI.
To account for the possible effect of repeat surgery on
ambulatory and living status we examined the group exclu-
sive of those who received repeat surgery. When we
Fig 1. Kaplan Meier curve of (A) primary, (B) assisted primary, and (C) secondary for male and female patients with
claudication and critical limb ischemia (CLI). CI, Conﬁdence interval; HR, hazard ratio; IC, intermittent claudication;
SE, standard error.
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patients who underwent repeat surgery for bleeding, infec-
tion, or thrombosis we found no change in our overall re-
sults for ambulatory or living status.
DISCUSSION
Despite a number of studies that examined the associ-
ation of gender on conventional outcomes such as patency,
morbidity, and mortality after LEB, few have focused on
functional outcomes according to gender.13-17 Clearly,
claudicants and CLI patients have differing patency and
survival rates with some reports suggesting inferior out-
comes in women.6-9,17 Although female gender has beenassociated with inferior technical outcomes and postopera-
tive complications, there is a lack of consistency in these
ﬁndings with some reporting no difference between gen-
ders. This association has been attributed to a variety of fac-
tors including delayed presentation, smaller vessel
diameter, advanced age, and increased propensity of post-
menopausal atherosclerosis.18
The primary clinical goals of LEB are to maintain func-
tion and preserve independence. Studies that only investi-
gate graft patency and limb salvage might fail to discover
an important loss of functional status or independence.
Several studies have identiﬁed predictors that negatively in-
ﬂuence functional outcomes after LEB. Abou-Zamzam
Fig 3. Kaplan-Meier curve of survival for male and female patients with claudication and critical limb ischemia (CLI).
CI, Conﬁdence interval; HR, hazard ratio; IC, intermittent claudication; SE, standard error.
Fig 2. Kaplan-Meier curve of freedom from amputation for male and female patients with claudication and critical limb
ischemia (CLI). CI, Conﬁdence interval; HR, hazard ratio; IC, intermittent claudication; SE, standard error.
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status were predictors of 6-month functional outcomes
for patients with CLI.1 In an analysis of VSGNE data,
Goodney et al found that age, preoperative ambulatorystatus, independent living status, CLI, and amputation pre-
dicted 1-year ambulatory status among claudicants and CLI
patients.3 Female gender was signiﬁcant in univariate anal-
ysis but gender was not an independent predictor of
Fig 4. Ambulatory status of patients with claudication (A) and
critical limb ischemia (CLI) (B) preoperatively, at discharge, and at
1-year follow-up according to gender. aP value adjusted for age,
race, smoking, preoperative ambulatory status, preoperative statin,
coronary artery disease, hypertension, conduit, graft origin, graft
recipient, and length of follow-up using logistic regression;
adjusted for indication using stratiﬁcation.
Fig 5. Living status of patients with claudication (A) and critical
limb ischemia (CLI) (B) preoperatively, at discharge, and at 1-year
follow-up according to gender. aP value adjusted for age, race,
smoking, preoperative ambulatory status, preoperative statin, cor-
onary artery disease, hypertension, conduit, graft origin, graft
recipient, and length of follow-up using logistic regression;
adjusted for indication using stratiﬁcation.
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conﬁrmed the importance of preoperative ambulatory status
among patients with CLI and found that infrainguinal dis-
ease, end-stage renal disease, presence of gangrene, and
hyperlipidemia are independent risk factors for achieving
clinical success including ambulation after LEB.19 Limb
loss in less than 1 year, homebound ambulation, dementia,
end-stage renal disease, diabetes, and female gender have
also been categorized as risk factors for deterioration of
ambulation amongCLI patients at 1 year after LEB.5 Taylor
et al evaluated 1000 limbs of patients who underwent open
and endovascular revascularization for CLI and found that
female gender was an independent risk factor associated
with deterioration of ambulation at 1 year, with no effect
on independent living status or mortality.5 Pulli et al specif-
ically investigated outcomes after percutaneous vascular
intervention of femoropopliteal disease among men and
women and found that both genders had similar rates of
technical success with a trend toward inferior primary and
assisted primary patency among women.20 Comparison be-
tween these studies is difﬁcult because of varying combina-
tions of open vs percutaneous revascularization and differing
deﬁnitions of ambulation and living status.
In this study, we found that women with CLI had
lower rates of primary, assisted primary, and secondary
patency at 1 year, however there were no genderdifferences in in-hospital or long-term mortality, and
amputation rates. Women with claudication had patency
and survival rates similar to men. Overall in-hospital
morbidity was similar between genders except for a 2%
higher rate of reoperation for graft thrombosis in women.
When we examined the entire spectrum of postoperative
complications this was the only statistically signiﬁcant dif-
ference. Taken together, the results bolster the evidence
that, except for reduced patency in patients with CLI,
women have outcomes that are very comparable to men
with regard to these standard end points.
Our study provides new insight into the functional out-
comes of women with claudication and CLI. Although we
found few differences between men and women in many of
the more traditional end points, we observed important dif-
ferences in functional outcomes between genders. Within
our study, female claudicants were less likely to ambulate
independently at discharge. Surprisingly, women with clau-
dication were three times more likely to be discharged to a
nursing home at a rate of 15%. Ultimately, however, female
claudicants showed no difference in ambulation or living
status at 1 year. In contrast, women with CLI showed infe-
rior outcomes for ambulation and independent living status
at discharge which persisted at the 1-year follow-up.
Although the absolute gender differences were small, re-
sults of this study suggest that there is a subset of women
at risk for unfavorable functional outcomes.
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comes of patients with claudication and CLI. We found
that more female claudicants required assistance with
ambulation and were admitted to a nursing home at
discharge. These gender differences for claudicants did
not persist at 1 year, suggesting women regained functional
status over time. We observed signiﬁcant differences in
ambulatory and living status among women with CLI
that persisted at 1 year.
Why do women have inferior functional outcomes
compared with men? Women have a longer life expec-
tancy, and it could be hypothesized that our results were
because of age discrepancies within the study cohort. Our
analysis was adjusted for age, and the differences seen in
functional outcomes are more likely multifactorial. Social
reasons might account for the early difference in fewer
women returning home after LEB. More women tend to
live alone and nursing home populations are >70%
women.21-23 Many women might be widowed and living
alone or have a partner who is unable to perform a caregiver
function. Moreover, women are more likely to serve as the
dominant caregivers of their male spouses despite having
similar functional impairment.20 The historical social role of
women as the caregiver might also account for these dis-
crepancies. Women might not have the social support or
extended family to provide the necessary care. A social
support network might be invaluable in the maintenance of
function and independence for women in particular.
A decrease in physical strength could also contribute to
inferior functional outcomes in women after LEB. Women
have a greater prevalence of disabling conditions such as
osteoporosis, osteoarthritis, and back problems, which
might further place them at risk for poorer postoperative
functional outcomes and loss of independent ambula-
tion.23,24 Early and consistent physical therapy could
beneﬁt women after LEB who might have pre-existing
conditions that might hinder baseline physical activity
and impair their postoperative recovery.
How can these data be helpful in clinical practice? First,
patients, families, and surgeons should take comfort in the
fact that the overall differences are fairly small. Second, the
informed consent process should reﬂect these small but sig-
niﬁcant differences. This will help set appropriate patient
and family expectations. Third, instituting a multidisci-
plinary care team including social workers, case managers,
visiting nurses, physical therapists, and rehabilitation spe-
cialists early in anticipation of more intense posthospital
care might lead to increased patient satisfaction and shorten
hospital length of stay. Further work is necessary to identify
the subset of women who are in greater need of social sup-
port after surgery.
Limitations to this work include the baseline differences
between men and women, which we accounted for in the
analysis. A small number in both groups were lost to long-
term follow-up. Body mass index data were not collected
during all years, so could not be analyzed, and might have
had an effect on functional status independent of gender.
Although previous peripheral vascular intervention wasrecorded in the database, information on laterality and type
of intervention were not captured. Certain variables such as
social support, history of dementia, primary caregiver status,
and the speciﬁc reason requiring a nursing home are not
captured in the VSGNE database and could have provided
insight into the underlying cause for loss of independent
ambulation and living among women. The speciﬁc reasons
for admission to a nursing home might vary based on fac-
tors such as other comorbidities and social support and
were not available in the data set. Although we recorded
ambulation and living status, we did not directly measure
quality of life using survey methods. Furthermore, we did
not record the extent of tissue loss for patients with CLI,
which could have inﬂuenced ambulation status. Because
readmission rates (not available in this data set) are coming
under increased scrutiny it would be of interest to deter-
mine if there are differences between genders in thismetric.
Our data mainly included Caucasian women in New
England and therefore our ﬁndings might not be general-
izable to all ethnic populations. Finally, we limited our
analysis to patients undergoing infrainguinal bypass. In
the future, we plan to investigate gender disparities
including technical and functional outcomes in patients
undergoing percutaneous vascular interventions to
improve patient and procedural selection for men and
women requiring treatment for peripheral arterial disease.
CONCLUSIONS
Women have similar postoperative outcomes, but
reduced patency rates and worse functional outcomes at
1 year after infrainguinal bypass predominantly in patients
with CLI. These ﬁndings might help deﬁne physician and
patient expectations for women before revascularization
and identify a group a patients in need of more intense ser-
vices after discharge from the hospital.
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Supplementary Table (online only). Multivariate
analysis of ambulatory and living status
ORa 95% CI P
Ambulatory status
Claudicants
Preoperative
With assistance vs independent 1.4 0.6-3.2 .40
Nonambulatory vs independent 0.6 0.05-5.7 .62
Discharge
With assistance vs independent 2.0 1.3-3.0 <.001
Nonambulatory vs independent 0.5 0.05-4.5 .51
One-year follow-up
With assistance vs independent 1.3 0.5-3.8 .59
Nonambulatory vs independent 4.9 0.7-33 .10
CLI
Preoperative
With assistance vs independent 1.2 0.9-1.6 .13
Nonambulatory vs independent 1.4 0.9-2.0 .13
Discharge
With assistance vs independent 1.3 1.0-1.6 .02
Nonambulatory vs independent 2.0 1.3-3.0 <.001
One-year follow-up
With assistance vs independent 1.4 1.0-2.0 .08
Nonambulatory vs independent 2.4 1.6-3.7 <.001
Living status, nursing home vs home
Claudicants
Preoperative 0 0-undeﬁned .99
Discharge 4.3 2.2-8.1 <.001
One-year follow-up 2.6 0.2-32 .46
CLI
Preoperative 0.9 0.5-1.4 .53
Discharge 1.3 1.1-1.7 .01
One year follow-up 1.7 1.1-2.8 .02
CI, Conﬁdence interval; CLI, critical limb ischemia; OR, odds ratio.
Nonambulatory includes wheelchair or bedridden.
aORs are for women vs men adjusting for covariates including age, race,
smoking, preoperative ambulatory status, preoperative statin, CAD, HTN,
conduit, graft origin, graft recipient, and length of follow-up using logistic
regression; adjusted for indication using stratiﬁcation.
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